Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1740-1747

  Nakanishi, Tsuyoshi ^a,b,c   Hayashi, Akira ^a,b,c   Kunisawa, Jun ^a,b,c   Tsutsumi, Yasuo ^a,b,c   Tanaka, Keiichi ^a,b,c   Yashiro Ohtani, Yumi ^a,b,c   Nakanishi, Mahito ^a,b,c   Fujiwara, Hiromi ^a,b,c   Hamaoka, Toshiyuki ^a,b,c   Mayumi, Tadanori ^a,b,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocyte; Fusogenic liposome; MHC class I; Ovalbumin; Vaccine

Indexed keywords

LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; ENCAPSULATION; ENDOCYTOSIS; ENDOSOME; FEMALE; IMMUNIZATION; MEMBRANE FUSION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SENDAI VIRUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CYTOPLASM; DRUG CARRIERS; ENDOCYTOSIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIPOSOMES; MEMBRANE FUSION; MICE; MICE, INBRED C57BL; OVALBUMIN; PHAGOCYTOSIS; SOLUBILITY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034037160     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U     Document Type: Article

References (37)

1. Rouse, B. T., Norley, S. and Martin, S., Antiviral cytotoxic T lymphocyte induction and vaccination. Rev. Infect. Dis. 1988. 10: 16-33.
2. Lukacher, A. E., Braciale, V. L. and Braciale, T. L., In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 1984. 160: 814-826.
3. Cerundolo, V., Lahaye, T., Horvath, C., Zanovello, P., Collavo, D. and Engers, H. D., Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSF-specific cytolytic T lymphocyte clones. Eur. J. Immunol. 1987.17:173-178.
4. Aldovini, A. and Young, R. A., Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 1991. 351: 479-482.
5. Schafer, R., Portnoy, D. A., Brassell, S. A. and Paterson, Y., Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol. 1992. 149:53-59.
6. Hahn, C. S., Hahn, Y. S., Braciale, T. J. and Rice, C. M., Infectious Sindbis virus transient expression vectors by studying antigen processing and presentation. Proc. Natl. Acad. Sei. USA 1992.89:2679-2683.
7. Guillaume, J. C., Saiag, P., Wechsler, J., Lèses, M. C. and Roujeau, J. C., Vaccinia from recombinant virus expressing HIV genes. Lancet 1991. 337:103-1035.
8. Townsend, A. R., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D. and McMichael, A. J., The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986.44: 959-968.
9. Van-Bleek, G. M. and Nathenson, S. G., Isolation of an endogenously processed immunodominant viral peptide from the class I H-2K6 molecule. Nature 1990. 348: 213-216.
10. Germain, R. N., The ins and outs of antigen processing and presentation. Nature 1986. 322: 687-689.
11. Harding, C. V. and Geuze, H. J., Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J. Immunol. 1993. 151:3988-3998.
12. Reddy, R., Zhou, F., Nair, S., Huang, L. and Rouse, B. T., In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol. 1992.148:1585-1589.
13. Jondal, M., Schirmbeck, R. and Reimann, J., MHC class Irestricted CTL responses to exogenous antigens. Immunity 1996. 5: 295-302.
14. Nakanishi, M., Mizuguchi, H., Ashihara, K., Senda, T., Akuta, T., Okabe, J., Nagoshi, E., Masago, A., Eguchi, A., Suzuki, Y., Inokuchi, H., Watabe, A., Ueda, S., Hayakawa, T. and Mayumi, T., Gene transfer vectors based on. Sendai virus. J. Control. Release 1998. 54:61-68.
15. Mizuguchi, H., Nakanishi, M., Nakanishi, T., Nakagawa, T., Nakagawa, S. and Mayumi, T., Application of fusogenic lipo-somes containing fragment A of diphtheria toxin to cancer therapy. Br. J. Cancer 1996. 73: 472-476.
16. Mizuguchi, H., Nakagawa, T., Toyosawa, S., Nakanishi, M., Imazu, S., Nakanishi, T., Tsutsumi, Y., Nakagawa, S., Hayakawa, T., ljuhin, N. and Mayumi, T., Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors. Cancer Res. 1998. 58: 5725-5730.
17. Mizuguchi, H., Nakagawa, T., Nakanishi, M., Imazu, S., Nakagawa, S. and Mayumi, T., Efficient gene transfer into mammalian cells fusogenic liposome. Biochem. Biophys. Res. Commun. 1996.218:402-407.
18. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. and Rock, K. L, Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. A/a/J. Acad. Sei. USA 1993. 90:4942-4946.
19. Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R. N. and Berzofsky, J. A., Induction of CDS' cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 1990. 344: 873-875.
20. Ke, Y., Li, Y. and Kapp, J. A., Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Bur. J. Immunol. 1995.25:549-553.
21. Ozawa, M., Asano, A. and Okada, Y., The presence and cleavage of interpeptide disulfide bonds in viral glycoproteins. J. Biochem. (Tokyo) 1979. 86:1361-1369.
22. Asano, K., Murachi, T. and Asano, A., Structural requirements for hemolytic activity of F-glycoprotein of HVJ (Sendai virus) studies by proteolytic dissection. J. Biochem. (Tokyo) 1979. 93: 733-741.
23. Goldberg, A. L. and Rock, K. L., Proteolysis, proteasomes and antigen presentation. Nature 1992. 357: 375-379.
24. Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L. and Rock, K. L., Lactacystin and clastolactacystin beta-lactone modify multiple proteasome betasubunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. B/ol. Chem. 1997. 272: 13437-13445.
25. Rock, K. L., Gramm, C., Rothstein, L, Clark, K., Stein, R., Dick, L., Hwang, D. and Goldberg, A. L., Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994.78:761-771.
26. Harding, C. V. and Song, R., Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 1994.153:4925-4933.
27. Attaya, M., Jameson, S., Martinez, C. K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K. F., Bevan, M. J. and Monaco, J. J., Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 1992. 355: 647-649.
28. Moore, M. W., Carbone, F. R. and Bevan, M. J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
29. Lee, K. D., Oh, Y. K., Portnoy, D. A. and Swanson, J. A., Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J. Biol. Chem. 1996. 271:7249-7252.
30. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J. and Harding, C. V., Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993. 361: 359-362.
31. Rodriguez, A., Regnault, A., Kleijmeer, M., RicciardiCastagnoli, P. and Amigorena, S., Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. War. Cell Biol. 1999.1: 362-368.
32. Shen, Z., Reznikoff, G., Dranoff, G. and Rock, K. L., Cloned dendritc cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 1997. 158: 2723-2730.
33. Miller, M. D., Gould-Fogerite, S., Shen, L., Woods, R. M., Koenig, S., Mannino, R. J. and Letvin, N. L., Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CDS' cytotoxic T lymphocytes. J. Exp. Med. 1992.176:1739-1744.
34. Gould-Fogerite, S. and Mannino, R. J., Rotary dialysis: its application to the preparation of large liposomes and large proteoliposimes (protein-lipid vesicles) with high encapsulation efficiency and efficient reconstitution of membrane proteins. Anal. Biochem 1985.148:15-25.
35. Hayashi, A., Nakanishi, T., Kunisawa, J., Kondoh, M., Imazu, S., Tsutsumi, Y., Tanaka, K., Fujiwara, H., Hamaoka, T. and Mayumi, T., A novel vaccine delivery system using immunopotentiating fusogenic liposomes. Biochem. Biophys. Res. Commun. 1999. 261: 824-828.
36. Mizuguchi, H., Nakanishi, T., Kondoh, M., Nakagawa, T., Nakanishi, M., Matsuyama, T., Tsutsumi, Y., Nakagawa, S. and Mayumi, T., Fusion of Sendai virus with liposome depends on only F protein, but not HN protein. Virus Res. 1999. 59: 191-201.
37. Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., Fujiwara, H., Hamaoka, T. and Mayumi, T., Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun. 1997. 240: 793-797.